SCHEMBL5310753

SCHEMBL5310753

CCCO/N=C(\COc1cc(CO)cc(C(=O)O)c1)c1cc(-c2ccc(F)cc2)no1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 4/20 0.39
▸ MAPT P10636 6/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ TP53 P04637 1/20 0.36
▸ PPARG P37231 2/20 0.36
▸ PPARA Q07869 2/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RAB9A P51151 3/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ F2 P00734 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ CSGALNACT1 Q8TDX6 1/20 0.34
▸ GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5310760 1.00 PTPN1 (0.39) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5310817 0.92 MAPT (0.38) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5310823 0.92 MAPT (0.38) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5334207 0.90 PTPN1 (0.38) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5334200 0.90 PTPN1 (0.38) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5310820 0.89 PTPN1 (0.40) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5310815 0.89 PTPN1 (0.40) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5316141 0.88 PTPN1 (0.38) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5316162 0.88 PTPN1 (0.38) PTPN1MAPTLMNASMN1; SMN2TP53
SCHEMBL5316148 0.88 PTPN1 (0.38) PTPN1MAPTLMNASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 — — WO disclosed
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 — — WO disclosed
Send feedback